China News Service, December 17th (Chen Jing Zhongxuan) As China's urban population continues to age, the absolute incidence of prostate cancer will continue to increase.

It is an indisputable fact that the proportion of patients with early prostate cancer is low and the survival rate is not good.

　　Professor Ye Dingwei of the Department of Urology, Fudan University Cancer Hospital told reporters on the 17th that the improvement of the curative effect of prostate cancer patients should not only focus on the treatment side, but should move the “gateway” of early screening further forward.

　　The expert bluntly stated in an interview that due to the lack of a systematic early screening system, the proportion of early prostate cancer patients diagnosed in China is less than 40%, which is much lower than the 80% early screening rate in advanced developed countries in Europe and the United States during the same period.

He said that patients with advanced metastatic prostate cancer accounted for about 30%, much higher than the 4% in developed countries in Europe and America during the same period.

　　It is understood that the peak incidence of prostate cancer in urban areas of China starts at the age of 60, which is 10 years later than the 50-year-old peak in the United States.

The five-year survival rate of prostate cancer is much lower than that of advanced countries in Europe and America.

Ye Dingwei said that if the proportion of early detection of patients jumps substantially, the overall survival rate of Chinese prostate cancer patients will surely be improved to a greater extent.

From the perspective of health economics, patients can get a basic healing effect at a very low cost.

　　In recent years, the team led by Ye Dingwei has been committed to accurate early screening of prostate cancer and is leading the formulation of the "Chinese Expert Consensus on Prostate Cancer Screening."

Accordingly, men older than 50 years old, men older than 45 years old and have a family history of prostate cancer are all high-risk groups.

　　During the interview, the reporter learned that a project called "Urinary Tumor Basic Level Tour and Prostate Cancer Screening" has been in operation for 3 years since its inception in 2017.

The project leader, Professor Qin Xiaojian of Department of Urology, Fudan University Cancer Hospital, told reporters that the Department of Urology had visited 25 communities and covered the whole area of ​​Shanghai, accurately screened 3,502 people, and found 44 patients with early prostate cancer, of which 35 were in the For a while, they were referred to the Fudan University Affiliated Tumor Hospital for radical surgery through the green channel, which greatly improved the 5-year survival rate of these "latent" patients.

　　On the 17th, the Cancer Hospital of Fudan University (Pudong District) officially opened the "Prostate Cancer Screening Clinic", which will carry out disease risk assessment, free testing, report interpretation, and green access to hospitals for high-risk groups of prostate cancer. Station-based diagnosis and treatment services have moved the threshold of early prostate cancer screening "a big step."

　　The first patient, Mr. Zhu, told reporters that his 73-year-old father was a prostate cancer patient treated in the hospital. He was worried that he would be a high-risk group of prostate cancer and came to consult.

Qin Xiaojian inquired about Mr. Zhu's medical history in detail, combined with clinical characteristics, and made a risk assessment. After examination, Mr. Zhu's blood test indicators were normal.

Qin Xiaojian advises Mr. Zhu on screening and daily healthy living.

　　Qin Xiaojian told reporters that for patients with abnormal indicators and high suspicion of prostate cancer, the outpatient clinic will launch a green channel to give patients a one-stop diagnosis and treatment experience from "early screening-timely admission-follow-up recovery".

In addition, for those who have been diagnosed with prostate cancer and have not yet received surgical treatment, the clinic will help them to be evaluated and admitted as soon as possible to undergo surgery.

(Finish)